The menopause transition: Endocrine changes and clinical symptoms

Journal of the British Menopause Society

Volumn 11, Issue 2, 2005, Pages 61-65

  Buckler, Helen ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Estradiol; Follicle stimulating hormone; Inhibin; Menopause transition; Oocyte

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE GLUCURONIDE; FOLLITROPIN; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN; INHIBIN; LIPID; LUTEINIZING HORMONE; PRASTERONE SULFATE; PREGNANEDIOL; PROGESTERONE; TESTOSTERONE; TRIACYLGLYCEROL;

ADULT; AMENORRHEA; BONE TURNOVER; CELL COUNT; DISTRESS SYNDROME; ENDOCRINOLOGY; FEMALE; HORMONE DEFICIENCY; HORMONE RELEASE; HUMAN; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; OOCYTE; OSTEOPOROSIS; OVULATION; PATHOPHYSIOLOGY; PHASE TRANSITION; POSTMENOPAUSE; REVIEW; SEXUAL DYSFUNCTION; SYMPTOM; VASOMOTOR DISORDER;

AGED; ENDOCRINE SYSTEM; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HORMONES; HUMANS; INHIBINS; LUTEINIZING HORMONE; MENOPAUSE; MIDDLE AGED; OVARY; PROGNOSIS;

EID: 21044459997     PISSN: 13621807     EISSN: None     Source Type: Journal    
DOI: 10.1258/136218005775544525     Document Type: Review

References (53)

1. McKinlay SM, Brambilla DJ, Postner JG. The normal menopause transition. Maturitas 1992;14:103-15
2. Treolar AE. Menstrual cyclicity and the pre-menopause. Maturitas 1981;3:249-64
3. Utian WH. The International Menopause Society. Menopause-related terminology definitions. Climacteric 1999; 2:284-6
4. Soules MR, Sherman S, Parrott E, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW), Park City, Utah, July, 2001. Menopause 2001;8:402-7
5. Block E. Quantitative morphological investigations of the follicular system in women. Acta Anat 1952;14:108-23
6. Baker TG. A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond Biol 1963;158:417-33
7. Richardson SJ, Senicas V, Nelson JF. Follicular depletion during the menopausal transition - evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 1987;65:1231-5
8. Treolar AR, Bounton RE, Behn BG, Brown BW. Variation of the human menstrual cycle throughout reproductive life. Int J Infertil 1967;12:77-9
9. Metcalf MG, Livesey JH. Gonadotrophin excretion in fertile women. Effect of age and the onset of menopausal transition. J Endocrinol 1985;105:357-62
10. Ahmed Ebbiary NA, Lenton EA, Salt C, Ward AM, Cooke ID. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Hum Reprod 1994; 9:245-52
11. Reyes FI, Winter JSD, Faiman C. Pituitary and ovarian relationships preceding the menopause. Am J Obstet Gynecol 1977; 129:557-64
12. Lee SJ, Lenton EA, Sexton L, Cooke ID. The effect on the cyclical patterns of plasma LH, FSH, oestradiol and progesterone in women with regular menstrual cycles. Hum Reprod 1998;3:851-5
13. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975;55:699-706
14. Sherman BM, West JH, Korenman SG. The menopausal transition - analysis of LH, FSH, oestradiol and progesterone concentrations during menstrual cycles of older women. J Clin Endocrinol Metab 1976; 42:629-34
15. Landgren BM, Collins A, Csemiczky G, et al. Menopause transition: annual changes in serum hormonal patterns over the menstrual cycle in women during a nine-year period prior to menopause. J Clin Endocrinol Metab 2004;89:2763-9
16. Metcalf MG, Donald RA, Livesey JH. Pituitary and ovarian function in normal women during the menopausal transition. Clin Endocrinol 1981;14:245-55
17. Miro F, Parker SW, Aspinall LJ, et al. Relationship between FSH levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM study. J Clin Endocrinol Metab 2004;89:3270-5
18. Miro F, Parker SW, Aspinall LJ, et al. Development of a sequential classification of the endocrine stages involved in the process of reproductive aging in women: the FREEDOM study. J Clin Endocrinol Metab 2005 (in press)
19. Burger HG, Dudley EC, Robertson DM, Dennerstein L. Hormonal changes in the menopause transition. Recent Prog Horm Res 2002; 57:257-75
20. Papanicolaou AD, Loraine JA, Dove GA, Loudon NB. Hormone excretion patterns in menopausal women. Br J Obstet Gynaecol 1969;76:308-16
21. Adampoulis DA, Loraine JA, Dove GA. Endocrinological studies in women approaching the menopause. Br J Obstet Gynaecol 1971; 76:62-79
22. MacNaughton J, Bangah M, McCloud P, et al. Age related changes in follicle stimulating hormone, lutinising hormone, oestradiol and immuno-reactive inhibin in women of reproductive age. Clin Endocrinol 1992;36:339-45
23. Santoro N, Rosenberg-Brown J, Adel T. Skurnick JH. Characterisation of reproductive hormonal dynamics in the perimenopause. J Clin Endocrinol Metab 1996;81:1495-501
24. Klein NA, Battaglia DE, Fujimoto VY, et al. Reproductive aging: accelerated ovarian follicular development associated with a monotrophic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol 1996;81:1038-48
25. Klein NA, Battaglia DE, Miller PB, et al. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age. J Clin Endocrinol Metab 1996;81:1946-51
26. Rannevik G, Jeppsson S, Johnell O. et al. Longitudinal study of the perimenopausal transition: altered profiles of steroid and pituitary hormones, SHBG and bone density. Maturitas 1995; 21:103-13
27. Petsos P, Buckler H, Mamtora H, Anderson D. Ovulation after treatment with ethinyl oestradiol and medroxprogesterone acetate in a woman approaching premature menopause. Br J Obstet Gynaecol 1986; 93:1155-60
28. Longcope C, Franz C, Morello C, et al. Steroid and gonadotrophin levels in women during the perimenopausal years. Maturitas 1980;8:189-96
29. Zumoff B, Staine GWE, Miller LK, Rosner W. 24 hour mean plasma testosterone concentration declines with age in normal pre-menopausal women. J Clin Endocrinol Metab 1995; 80:1429-30
30. Mushayandabu T, Castracane VD, Gimpel T, et al. Evidence for diminished mid-cycle ovarian androgen production in older reproductive age women. Fertil Steril 1996;65:721-3
31. Burger HG, Dudley EC, Cui J, et al. A prospective longitudinal study of serum testosterone dihydroepiandrosterone sulphate and sex hormone binding globulin levels through the menopause transition. J Clin Endocrinol Metab 2000;85:2832-8
32. Buckler HM, Robertson WR, Wu FC. Which androgen replacement therapy for women? J Clin Endocrinol Metab 1998;83:3920-4
33. Groome NP, Illingworth PJ, O'Brien M, et al. Quantitation of inhibin pro-alpha C containing forms in human serum by a new ultrasensitive two site enzyme linked immunosorbent assay. J Clin Endocrinol Metab 1996;80:2926-32
34. Groome N, O'Brien M. Immunoassays for inhibin and its subunits - further application of the synthetic peptide approach. J Immunolog Methods 1993;165:167-76
35. Sharara FI, Scott RT, Seifer DB. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998; 179:804-12
36. Seifer DB, Lambert-Messerlian G, Hogan JW, et al. Day 3 serum inhibin B is predictive of assisted reproductive technologies outcome. Fertil Steril 1997;68:947-8
37. Eldar-Geva T, Robertson DM, Cahir N, et al. Relationship between serum inhibin A and B and ovarian follicle development following a daily fixed dose administration of recombinant FSH. J Clin Endocrinol Metab 2000;85:607-13
38. Toner JP, Philput CB, Jones GS, Muashen SJ. Basal follicle stimulating hormone level is a better predictor of an in-vitro fertilization programme than age. Fertil Steril 1991; 55:784-8
39. Abdalla H, Thum MY. An elevated basal FSH reflects a quantitative rather than qualitative decline of the ovarian reserve. Hum Reprod 2004;19:893-8
40. Lockwood G. The diagnostic value of inhibin in infertility evaluation. Semin Reprod Med 2004;22:195-208
41. Buckler HM, Evans CA, Mamtora H, et al. Gonadotrophin steroid and inhibin levels in women with incipient ovarian failure in anovulatory and ovulatory rebound cycles. J Clin Endocrinol Metab 1991;72:116-24
42. Santoro N, Adel T, Skurnick JH. Decreased inhibin tone and increased activin A secretion characterise reproductive ageing in women. Fertil Steril 1999;71:658-62
43. Klein NA, Illingworth PJ, Groome MP, et al. Decreased inhibin B secretion is associated with a monotrophic FSH rise in older ovulatory women - a study of serum and follicular fluid levels of dymeric inhibin A and B in spontaneous menstrual cycle. J Clin Endocrinol Metab 1996;81:2742-5
44. Reame NE, Wyman TL, Phillips DJ, de Kretser DM, Padmanabhan V. Net increase in stimulatory input resulting from a decrease in inhibin B and an increase in activan A may contribute in part to the rise in follicular phase follicle stimulating hormone of aging cycling women. J Clin Endocrinol Metab 1998;83:3302-7
45. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive ageing is marked by decreased secretion of dymeric inhibin. J Clin Endocrinol Metab 1999;84:105-11
46. Burger HG, Cahir N, Robertson DM, et al. Serum inhibins A and B fall differentially as FSH rises in perimenopausal women. Clin Endocrinol 1998;48:809-13
47. Burger HG, Dudley EC, Hopper JL, et al. Prospectively measured levels of follicle stimulating hormone, oestradiol and the dymeric inhibins during the menopausal transition in a population based cohort of women. J Clin Endocrinol Metab 1999;84:4025-30
48. Dennerstein L, Dudley EC, Hopper JL, et al. A prospective population based study of menopausal symptoms. Obstet Gynecol 2000;96:351-8
49. Bosworth HB, Bastian LA, Kuchibhatla MN, et al. Depressive symptoms, menopausal status, and climacteric symptoms in women at midlife. Psychosom Med 2001;63:603-8
50. Guthrie JR, Ebeling PR, Hopper LJ, et al. A prospective study of bone loss in menopausal Australian borne women. Osteoporosis Int 1998;19:165-73
51. Kroger H, Tuppurainen M, Honkanen R, et al. Bone mineral density and risk factors for osteoporosis - a population-based study of 1600 perimenopausal women. Calcif Tissue Int 1994; 55:1-7
52. Sirola J, Kroger H, Honkanen R, et al. OSTPRE Study Group. Factors affecting bone loss around menopause in women without HRT: a prospective study. Maturitas 2003;45:159-67
53. Hall G, Collins A, Csemiczky G, Landgren BM. Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women. Maturitas 2002; 41:177-85